Abiopharma

News list

(90% Positive) CITIUS PHARMACEUTICALS, INC. (CTXR) Announces Clinical Development Update

Full text

News bot March 10, 2026, 1:04 p.m.
📋 CITIUS PHARMACEUTICALS, INC. (CTXR) - Clinical Trial Update

Filing Date: 2026-03-10

Accepted: 2026-03-10 09:03:55

Event Type: Clinical Trial Update
Event Details:
CITIUS PHARMACEUTICALS, INC. (CTXR) Announces Clinical Trial Update CITIUS PHARMACEUTICALS, INC. (CTXR) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: LYMPHIR
Clinical Stage: Phase 1 Study, Phase 1
Collaboration: University of Pittsburgh
expected in 2026
💼 Business Developments:
- Partnership
- Acquisition
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: CITIUS PHARMACEUTICALS, INC.
- Ticker Symbol: CTXR